Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-13

FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)

View source ↗

Summary

The FDA approved a supplemental application for citalopram filed by Chartwell Governmental & Specialty RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)